Haemophilus Influenza Type B
2 clinical trials · Condition
◉ Watch Haemophilus Influenza Type B
| Record | Firm | Date |
|---|---|---|
| Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks (NCT02257645) | LG Life Sciences | 2015-03-01 |
| Exploratory Clinical Study of MT-2301 (NCT02140047) | Tanabe Pharma Corporation | 2014-04-01 |
Track Haemophilus Influenza Type B automatically
Every clearance here is in the API, with alerts when new ones post.